Our products in the Middle East and North Africa

We provide branded generic medicines and generic injectable products across the MENA.

Related news

Hikma and Junshi Biosciences sign exclusive licensing agreement for cancer treatment drug toripalimab for the Middle East and North Africa region
26 December 2022
Hikma expands licensing agreement with Celltrion for Remsima® subcutaneous formulation in MENA
7 February 2022
Hikma signs license agreement with Medicine Patent Pool for molnupiravir
20 January 2022

Last reviewed on 30 May 2022